Abbas Lugemwa

1.3k total citations
5 papers, 69 citations indexed

About

Abbas Lugemwa is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Abbas Lugemwa has authored 5 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Abbas Lugemwa's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Abbas Lugemwa is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Abbas Lugemwa collaborates with scholars based in United Kingdom, Uganda and Zimbabwe. Abbas Lugemwa's co-authors include Godfrey Musoro, Nicholas I. Paton, Diana M. Gibb, JA Thompson, Shafic Makumbi, Hellen Musana, Aggrey Mweemba, Carlo Giaquinto, Dickens Atwongyeire and David M. Burger and has published in prestigious journals such as BMC Medical Research Methodology, Journal of NeuroVirology and Antiviral Therapy.

In The Last Decade

Abbas Lugemwa

5 papers receiving 69 citations

Peers

Countries citing papers authored by Abbas Lugemwa

Since Specialization

Citations

This map shows the geographic impact of Abbas Lugemwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Lugemwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Lugemwa more than expected).

Fields of papers citing papers by Abbas Lugemwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbas Lugemwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Lugemwa. The network helps show where Abbas Lugemwa may publish in the future.

Co-authorship network of co-authors of Abbas Lugemwa

This figure shows the co-authorship network connecting the top 25 collaborators of Abbas Lugemwa. A scholar is included among the top collaborators of Abbas Lugemwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbas Lugemwa. Abbas Lugemwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial 2022 ·BMC Medical Research Methodology ·Rebecca Turner, Anna Turkova, (unknown), Alasdair Bamford, Moherndran Archary, Linda Barlow‐Mosha, Mark F. Cotton, Tim R. Cressey, Elizabeth Kaudha, Abbas Lugemwa, Hermione Lyall, Hilda Mujuru, Veronica Mulenga, Victor Musiime, Pablo Rojo, Gareth Tudor‐Williams, Steven Welch, Diana M. Gibb, Deborah Ford, Ian R. White, (unknown)	5
2	Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial 2022 ·The Lancet HIV ·Hylke Waalewijn, Man K. Chan, (unknown), Hilda Mujuru, Shafic Makumbi, Adeodata Kekitiinwa, Elizabeth Kaudha, (unknown), Godfrey Musoro, (unknown), Abbas Lugemwa, Pauline Amuge, (unknown), Pablo Rojo, Carlo Giaquinto, Angela Colbers, Diana M. Gibb, Deborah Ford, Anna Turkova, David M. Burger	14
3	Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial 2020 ·The Lancet HIV ·(unknown), Cecilia L. Moore, Hilda Mujuru, Shafic Makumbi, Adeodata Kekitiinwa, (unknown), Anna Parker, Godfrey Musoro, (unknown), Abbas Lugemwa, Pauline Amuge, James Hakim, Pablo Rojo, Carlo Giaquinto, Angela Colbers, Diana M. Gibb, Deborah Ford, Anna Turkova, David M. Burger	21
4	HIV-1 Viral Load and Resistance in Genital Secretions in Patients Taking Protease-Inhibitor-Based Second-Line Therapy in Africa 2017 ·Antiviral Therapy ·Anne Hoppé, Marina Giuliano, Abbas Lugemwa, JA Thompson, Marco Floridia, A. Sarah Walker, (unknown), M Abwola, Maria Franca Pirillo, Cissy Kityo, Alejandro Arenas‐Pinto, Nicholas I. Paton, (unknown)	2
5	Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial 2015 ·Journal of NeuroVirology ·(unknown), Alejandro Arenas‐Pinto, JA Thompson, Godfrey Musoro, Hellen Musana, Abbas Lugemwa, Andrew Kambugu, Aggrey Mweemba, Dickens Atwongyeire, Margaret J. Thomason, A Sarah Walker, Nicholas I. Paton	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact